Rapt Therapeutics (RAPT) PT Lowered to $42 at JPMorgan
Tweet
Share
E-mailGet Alerts RAPT Hot Sheet
Price: $58.02 --0%
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Rating Summary:
7 Buy, 13 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on Rapt Therapeutics (NASDAQ: RAPT) to $42.00 (from $48.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Ooma (OOMA) PT Raised to $24 at Freedom Broker
- Raycus Fiber Laser (300747:CH) PT Raised to RMB16.70 at Goldman Sachs
- SolarEdge (SEDG) PT Lowered to $31 at Jefferies, 'We see shares as an unappealing short, not a compelling long'
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
